Page last updated: 2024-08-24

cephalosporin c and avibactam

cephalosporin c has been researched along with avibactam in 55 studies

Research

Studies (55)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (1.82)	29.6817
2010's	29 (52.73)	24.3611
2020's	25 (45.45)	2.80

Authors

Authors	Studies
Black, MT; Claudon, M; Girard, AM; Levasseur, P; Miossec, C; Péchereau, MC; Stachyra, T	1
Critchley, I; Livermore, DM; Mushtaq, S; Warner, M; Williams, G	1
Crandon, JL; Furtado, GH; Nicolau, DP; Williams, G; Wiskirchen, DE	1
Brown, D; Castanheira, M; Critchley, I; Drusano, GL; Grasso, C; Jones, RN; Kulawy, R; Liu, W; Louie, A; Thye, D; Vanscoy, B; Williams, G	1
Barker, K; Hope, R; Livermore, DM; Mushtaq, S; Warner, M; Woodford, N	1
Castanheira, M; Farrell, DJ; Jones, RN; Mendes, RE; Sader, HS	1
Rank, D; Riccobene, TA; Su, SF	1
Flamm, RK; Jones, RN; Sader, HS	1
Citron, DM; Goldstein, EJ; Merriam, CV; Tyrrell, KL	1
Adam, HJ; Baxter, MR; Hoban, DJ; Karlowsky, JA; Lagacé-Wiens, PR; Walkty, AJ; Zhanel, GG	1
Bhalodi, AA; Crandon, JL; Nicolau, DP; Williams, G	2
Armstrong, J; Das, S; Edeki, T; Li, J; Mathews, D	1
Rybak, MJ; Werth, BJ	1
Farrell, DJ; Flamm, RK; Jones, RN; Sader, HS	1
Castanheira, M; Jones, RN; Sader, HS; Williams, G	1
Arthur, M; Cortes, M; Dubée, V; Gutmann, L; Hugonnet, JE; Lefebvre, AL; Mainardi, JL; Soroka, D	1
Abdelhamed, AM; Bajaksouzian, S; Bonomo, RA; Foster, AN; Gatta, JA; Jacobs, MR; Nichols, WW; Papp-Wallace, KM; Testa, R; Winkler, ML	1
Nord, CE; Panagiotidis, G; Rashid, MU; Rosenborg, S; Söderberg-Löfdal, K; Weintraub, A	1
Bonomo, RA; van Duin, D	1
Cannatelli, A; Di Pilato, V; Giani, T; Nichols, WW; Rossolini, GM; Testa, R	1
Baumert, P; Feihl, S; Gastmeier, P; Gebhardt, F; Gölz, H; Hamprecht, A; Kern, WV; Knobloch, J; Kola, A; Mischnik, A; Obermann, B; Peter, S; Querbach, C; Rohde, A; Seifert, H; Tacconelli, E; Willmann, M	1
Bowker, K; MacGowan, A; Noel, A; Tomaselli, S	1
Arthur, M; Ourghanlian, C; Soroka, D	1
Dubois, V; Jayol, A; Kieffer, N; Nordmann, P; Ortiz De La Rosa, JM; Poirel, L	1
Cheng, J; Feng, X; Hu, Y; Huang, W; Huang, X; Jin, Y; Liao, K; Liu, Y; Lu, J; Xu, Y; Yang, Q; Yu, Y; Zhang, S; Zhou, M	1
Hsu, AJ; Tamma, PD	1
Humphries, RM; Spafford, K	1
Bonomo, RA; Evans, SR	1
Baklouti, S; Concordet, D; Gandia, P; Guet-Revillet, H; Mane, C; Massip, C; Murris, M	1
Iredell, JR; Khalid, A; Lin, RCY; Lubián, AF; Ma, L	1
Fraile-Ribot, PA; Khajehpour, M; Mark, BL; Oliver, A; Slater, CL; Winogrodzki, J	1
Bacca, E; Bedini, A; Bianco, V; Cuomo, G; Franconi, I; Meschiari, M; Mussini, C; Orlando, G	1
Arca-Suárez, J; Beceiro, A; Bou, G; Cabot, G; Galán-Sánchez, F; González-Bello, C; Lasarte-Monterrubio, C; Oliver, A; Rodiño-Janeiro, BK; Rodríguez-Iglesias, M; Vázquez-Ucha, JC	1
Bian, H; Chen, L; Dong, X; Shen, Z; Sheng, S; Xu, W; Yu, J; Zhang, J	1
Bauer, T; Berbescu, S; Bouchand, F; Davido, B; de Laroche, M; Dinh, A; Duran, C; Matt, M; Nich, C; Noussair, L; Pagis, V; Rempenault, C; Rottman, M; Salomon, E	1
Daragon, B; Fournier, D; Jeannot, K; Plésiat, P	1
Hsueh, PR; Huang, YT; Kuo, YW; Liao, CH; Teng, LJ	1
Castanheira, M; Duncan, LR; Mendes, RE; Sader, HS	1
Meesing, A; Sribenjalux, W; Wonglakorn, L	1
Alonso-García, I; Arca-Suárez, J; Beceiro, A; Bou, G; Fernández-Pérez, B; Fraile-Ribot, PA; Gato, E; González-Bello, C; Guijarro-Sánchez, P; Gutiérrez-Urbón, JM; Lasarte-Monterrubio, C; Oliver, A; Oviaño, M; Ruedas-López, A; Vallejo, JA; Vázquez-Ucha, JC; Velasco, D	1
Cappellano, P; de Lima, AV; Lima, KO; Rocha, DADC; Sampaio, JLM; Sampaio, SCF	1
Amadesi, S; Ambretti, S; Gaibani, P; Lazzarotto, T	1
Carvalhaes, CG; Castanheria, M; Duncan, LR; Mendes, RE; Sader, HS	1
Alonso-García, I; Arca-Suárez, J; Beceiro, A; Bou, G; Cabot, G; Fraile-Ribot, PA; Galán-Sánchez, F; Guijarro-Sánchez, P; Lasarte-Monterrubio, C; Oliver, A; Rumbo-Feal, S; Vázquez-Ucha, JC	1
Baretta, V; Calore, E; Carraro, F; Cesaro, S; Colombini, A; Meazza, C; Muggeo, P; Onofrillo, D; Perruccio, K; Rosaria D'Amico, M; Zama, D	1
Hua, X; Lei, T; Leptihn, S; Liu, H; Liu, X; Yang, Y; Yu, Y; Zhang, L	1
Gill, CM; Nicolau, DP	1
Stamm, P; Urmann, E; Wisskirchen, J	1
Aja-Macaya, P; Alonso-García, I; Arca-Suárez, J; Beceiro, A; Bou, G; Fernández-González, A; Galán-Sánchez, F; González-Mayo, E; Guijarro-Sánchez, P; Lada-Salvador, P; Lasarte-Monterrubio, C; Martínez-Guitián, M; Muíño-Andrade, M; Oliver, A; Rodríguez-Iglesias, M; Rumbo-Feal, S; Vázquez-Ucha, JC; Vela-Fernández, R	1
Le Terrier, C; Nordmann, P; Poirel, L; Sadek, M	1
Huang, E; Moon, SH	1
Hsueh, PR; Lee, YL	1
Feng, Y; Ma, K; Wu, S; Zong, Z	1
Al-Marzooq, F; Anes, F; Collyns, T; Daoud, L; Ghazawi, A	1

Reviews

3 review(s) available for cephalosporin c and avibactam

Article	Year
Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor Combinations. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016, 07-15, Volume: 63, Issue:2 Topics: Azabicyclo Compounds; beta-Lactamase Inhibitors; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Humans	2016
Defining the Role of Novel β-Lactam Agents That Target Carbapenem-Resistant Gram-Negative Organisms. Journal of the Pediatric Infectious Diseases Society, 2019, Jul-01, Volume: 8, Issue:3 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Boronic Acids; Carbapenems; Cefiderocol; Ceftazidime; Cephalosporins; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Heterocyclic Compounds, 1-Ring; Meropenem; Tazobactam	2019
Ceftazidime/avibactam and ceftolozane/tazobactam for the treatment of extensively drug-resistant Pseudomonas aeruginosa post-neurosurgical infections: three cases and a review of the literature. Infection, 2021, Volume: 49, Issue:3 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Male; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2021

Trials

3 trial(s) available for cephalosporin c and avibactam

Article	Year
Single- and multiple-dose study to determine the safety, tolerability, and pharmacokinetics of ceftaroline fosamil in combination with avibactam in healthy subjects. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:3 Topics: Adult; Anti-Bacterial Agents; Azabicyclo Compounds; Ceftaroline; Cephalosporins; Chromatography, Liquid; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Humans; Injections, Intravenous; Male; Middle Aged; Placebos; Tandem Mass Spectrometry	2013
Randomized, placebo-controlled study to assess the impact on QT/QTc interval of supratherapeutic doses of ceftazidime-avibactam or ceftaroline fosamil-avibactam. Journal of clinical pharmacology, 2014, Volume: 54, Issue:3 Topics: Adolescent; Adult; Anti-Bacterial Agents; Azabicyclo Compounds; Ceftaroline; Ceftazidime; Cephalosporins; Cross-Over Studies; Double-Blind Method; Electrocardiography; Heart Rate; Humans; Long QT Syndrome; Male; Middle Aged; Young Adult	2014
Ecological Effect of Ceftaroline-Avibactam on the Normal Human Intestinal Microbiota. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:8 Topics: Adult; Anti-Bacterial Agents; Azabicyclo Compounds; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Ceftaroline; Cephalosporins; Feces; Female; Gastrointestinal Microbiome; Healthy Volunteers; Humans; Male; Microbial Sensitivity Tests; Young Adult	2015

Other Studies

49 other study(ies) available for cephalosporin c and avibactam

Article	Year
In vitro activity of the {beta}-lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases. The Journal of antimicrobial chemotherapy, 2009, Volume: 64, Issue:2 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cephalosporins; Enterobacteriaceae; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure	2009
Activity of chequerboard combinations of ceftaroline and NXL104 versus beta-lactamase-producing Enterobacteriaceae. The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:7 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Ceftaroline; Cephalosporins; Drug Synergism; Enterobacteriaceae; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests	2010
In vivo efficacy of a human-simulated regimen of ceftaroline combined with NXL104 against extended-spectrum-beta-lactamase (ESBL)-producing and non-ESBL-producing Enterobacteriaceae. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:7 Topics: Animals; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Ceftaroline; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Thigh	2011
Pharmacodynamics of β-lactamase inhibition by NXL104 in combination with ceftaroline: examining organisms with multiple types of β-lactamases. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:1 Topics: Anti-Bacterial Agents; Area Under Curve; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Ceftaroline; Cephalosporins; Chromatography, Liquid; Drug Administration Schedule; Drug Dosage Calculations; Drug Resistance, Bacterial; Drug Synergism; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Biological; Tandem Mass Spectrometry	2012
Characterization of β-lactamase and porin mutants of Enterobacteriaceae selected with ceftaroline + avibactam (NXL104). The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:6 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Ceftaroline; Cephalosporins; Drug Resistance, Bacterial; Enterobacteriaceae; Genomic Instability; Microbial Sensitivity Tests; Mutant Proteins; Phenotype; Porins; Selection, Genetic	2012
Activity of ceftaroline-avibactam tested against Gram-negative organism populations, including strains expressing one or more β-lactamases and methicillin-resistant Staphylococcus aureus carrying various staphylococcal cassette chromosome mec types. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:9 Topics: Acinetobacter; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Ceftaroline; Cephalosporins; Chromosomes, Bacterial; Drug Combinations; Gram-Negative Bacterial Infections; Humans; Isoenzymes; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Plasmids; Pseudomonas aeruginosa; Staphylococcal Infections	2012
Antimicrobial activity of ceftaroline-avibactam tested against clinical isolates collected from U.S. Medical Centers in 2010-2011. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:4 Topics: Anti-Infective Agents; Azabicyclo Compounds; Ceftaroline; Cephalosporins; Drug Combinations; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Streptococcus pneumoniae	2013
Comparative in vitro activity of ceftaroline, ceftaroline-avibactam, and other antimicrobial agents against aerobic and anaerobic bacteria cultured from infected diabetic foot wounds. Diagnostic microbiology and infectious disease, 2013, Volume: 76, Issue:3 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacteria, Aerobic; Bacteria, Anaerobic; Bacteroides fragilis; beta-Lactam Resistance; Ceftaroline; Cephalosporins; Diabetes Complications; Drug Synergism; Enterobacter; Foot Diseases; Humans; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Morganella; Prevotella	2013
In vitro activity of ceftaroline-avibactam against gram-negative and gram-positive pathogens isolated from patients in Canadian hospitals from 2010 to 2012: results from the CANWARD surveillance study. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:11 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Canada; Ceftaroline; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Public Health Surveillance; Retrospective Studies	2013
In vivo efficacy of humanized ceftaroline fosamil-avibactam exposures in a polymicrobial infection model. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:11 Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; Bacteroides fragilis; Ceftaroline; Cephalosporins; Coinfection; Drug Administration Schedule; Drug Combinations; Enterobacter cloacae; Escherichia coli; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Immunocompromised Host; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Treatment Outcome	2013
Ceftaroline plus avibactam demonstrates bactericidal activity against pathogenic anaerobic bacteria in a one-compartment in vitro pharmacokinetic/pharmacodynamic model. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:1 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacteria, Anaerobic; Bacteroides fragilis; Ceftaroline; Cephalosporins; Microbial Sensitivity Tests; Prevotella	2014
Antimicrobial activity of ceftaroline combined with avibactam tested against bacterial organisms isolated from acute bacterial skin and skin structure infections in United States medical centers (2010-2012). Diagnostic microbiology and infectious disease, 2014, Volume: 78, Issue:4 Topics: Academic Medical Centers; Anti-Bacterial Agents; Azabicyclo Compounds; Bacteria; Ceftaroline; Cephalosporins; Humans; Microbial Sensitivity Tests; Skin Diseases, Bacterial; United States	2014
Activity of ceftaroline-avibactam tested against contemporary Enterobacteriaceae isolates carrying β-lactamases prevalent in the United States. Microbial drug resistance (Larchmont, N.Y.), 2014, Volume: 20, Issue:5 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Ceftaroline; Cephalosporins; Drug Combinations; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella; Microbial Sensitivity Tests; Prevalence; Proteus mirabilis; United States	2014
Supporting the ceftaroline fosamil/avibactam Enterobacteriaceae breakpoint determination using humanised in vivo exposures in a thigh model. International journal of antimicrobial agents, 2014, Volume: 44, Issue:6 Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Ceftaroline; Cephalosporins; Disease Models, Animal; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Reproducibility of Results; Thigh	2014
Impact of β-lactamase inhibition on the activity of ceftaroline against Mycobacterium tuberculosis and Mycobacterium abscessus. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:5 Topics: Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Ceftaroline; Cephalosporins; Mycobacterium; Mycobacterium tuberculosis	2015
Activities of ceftazidime, ceftaroline, and aztreonam alone and combined with avibactam against isogenic Escherichia coli strains expressing selected single β-lactamases. Diagnostic microbiology and infectious disease, 2015, Volume: 82, Issue:1 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Ceftaroline; Ceftazidime; Cephalosporins; Escherichia coli; Humans; Microbial Sensitivity Tests	2015
Inhibitory activity of avibactam against selected β-lactamases expressed in an isogenic Escherichia coli strain. Diagnostic microbiology and infectious disease, 2016, Volume: 86, Issue:1 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; Ceftaroline; Ceftazidime; Cephalosporins; Escherichia coli; Gene Expression; Humans; Microbial Sensitivity Tests	2016
Susceptibility to cephalosporin combinations and aztreonam/avibactam among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission. International journal of antimicrobial agents, 2017, Volume: 49, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamase Inhibitors; Cephalosporin Resistance; Cephalosporins; Clavulanic Acid; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Germany; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Tazobactam; Young Adult	2017
The pharmacodynamics of avibactam in combination with ceftaroline or ceftazidime against β-lactamase-producing Enterobacteriaceae studied in an in vitro model of infection. The Journal of antimicrobial chemotherapy, 2017, 03-01, Volume: 72, Issue:3 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Ceftaroline; Ceftazidime; Cephalosporins; Computer Simulation; Drug Therapy, Combination; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests	2017
Inhibition by Avibactam and Clavulanate of the β-Lactamases KPC-2 and CTX-M-15 Harboring the Substitution N Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:3 Topics: Amino Acid Motifs; Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamases; Ceftaroline; Ceftazidime; Cephalosporins; Clavulanic Acid; Cloning, Molecular; Drug Combinations; Escherichia coli; Gene Expression; Kinetics; Mutation; Recombinant Proteins; Reverse Genetics; Substrate Specificity	2017
Acquisition of Extended-Spectrum β-Lactamase GES-6 Leading to Resistance to Ceftolozane-Tazobactam Combination in Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:1 Topics: Amino Acid Substitution; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Drug Combinations; Gene Expression; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2019
In Vitro Activities of Ceftaroline/Avibactam, Ceftazidime/Avibactam, and Other Comparators Against Pathogens From Various Complicated Infections in China. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018, 11-13, Volume: 67, Issue:suppl_2 Topics: Acinetobacter; Anti-Bacterial Agents; Azabicyclo Compounds; Ceftaroline; Ceftazidime; Cephalosporins; China; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitalization; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Public Health Surveillance	2018
Letter to the Editor. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 10-30, Volume: 69, Issue:10 Topics: Azabicyclo Compounds; Ceftazidime; Cephalosporins; Pathology, Molecular; Pseudomonas aeruginosa; Tazobactam	2019
Reply to Humphrey and Spafford. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 10-30, Volume: 69, Issue:10 Topics: Azabicyclo Compounds; Ceftazidime; Cephalosporins; Pathology, Molecular; Pseudomonas aeruginosa; Tazobactam	2019
Comment on: In vitro activity of seven β-lactams including ceftolozane/tazobactam and ceftazidime/avibactam against Burkholderia cepacia complex, Burkholderia gladioli and other non-fermentative Gram-negative bacilli isolated from cystic fibrosis patients The Journal of antimicrobial chemotherapy, 2019, 10-01, Volume: 74, Issue:10 Topics: Azabicyclo Compounds; Burkholderia cepacia complex; Burkholderia gladioli; Ceftazidime; Cephalosporins; Cystic Fibrosis; Drug Combinations; Humans; Tazobactam	2019
Characterizing the role of porin mutations in susceptibility of beta lactamase producing Klebsiella pneumoniae isolates to ceftaroline and ceftaroline-avibactam. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 93 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Ceftaroline; Cephalosporins; Drug Resistance, Bacterial; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mutation; Porins	2020
Adding Insult to Injury: Mechanistic Basis for How AmpC Mutations Allow Pseudomonas aeruginosa To Accelerate Cephalosporin Hydrolysis and Evade Avibactam. Antimicrobial agents and chemotherapy, 2020, 08-20, Volume: 64, Issue:9 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Hydrolysis; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa	2020
Molecular mechanisms driving the in vivo development of OXA-10-mediated resistance to ceftolozane/tazobactam and ceftazidime/avibactam during treatment of XDR Pseudomonas aeruginosa infections. The Journal of antimicrobial chemotherapy, 2021, 01-01, Volume: 76, Issue:1 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Ceftazidime; Cephalosporins; Drug Combinations; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2021
Synthesis and in vitro antibacterial activity of new aminothiazole-oximepiperidone cephalosporins. Bioorganic & medicinal chemistry letters, 2021, 05-15, Volume: 40 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Cephalosporins; Drug Combinations; Gram-Negative Bacteria; Microbial Sensitivity Tests; Oximes; Piperidones; Thiazoles	2021
Treatment of bone and joint infections by ceftazidime/avibactam and ceftolozane/tazobactam: a cohort study. Journal of global antimicrobial resistance, 2021, Volume: 25 Topics: Aged; Azabicyclo Compounds; Ceftazidime; Cephalosporins; Cohort Studies; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Tazobactam	2021
Performance of disc diffusion, MIC gradient tests and Vitek 2 for ceftolozane/tazobactam and ceftazidime/avibactam susceptibility testing of Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy, 2021, 09-15, Volume: 76, Issue:10 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Cephalosporins; Drug Combinations; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2021
Comparison of Etest and broth microdilution for evaluating the susceptibility of Staphylococcus aureus and Streptococcus pneumoniae to ceftaroline and of carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa to ceftazidime/avibactam. Journal of global antimicrobial resistance, 2021, Volume: 26 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftaroline; Ceftazidime; Cephalosporins; Disk Diffusion Antimicrobial Tests; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Streptococcus pneumoniae	2021
Antimicrobial activities of ceftazidime/avibactam, ceftolozane/tazobactam, imipenem/relebactam, meropenem/vaborbactam, and comparators against Pseudomonas aeruginosa from patients with skin and soft tissue infections. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2021, Volume: 113 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Boronic Acids; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Soft Tissue Infections; Tazobactam	2021
In vitro susceptibility of Burkholderia pseudomallei isolates from Thai patients to ceftolozane/tazobactam and ceftazidime/avibactam. Journal of global antimicrobial resistance, 2022, Volume: 28 Topics: Azabicyclo Compounds; Burkholderia pseudomallei; Ceftazidime; Cephalosporins; Humans; Melioidosis; Pseudomonas aeruginosa; Tazobactam; Thailand	2022
Selection of AmpC β-Lactamase Variants and Metallo-β-Lactamases Leading to Ceftolozane/Tazobactam and Ceftazidime/Avibactam Resistance during Treatment of MDR/XDR Pseudomonas aeruginosa Infections. Antimicrobial agents and chemotherapy, 2022, 02-15, Volume: 66, Issue:2 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Ceftazidime; Cephalosporins; Drug Combinations; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2022
A simple disk pre-diffusion test to predict in vitro aztreonam/avibactam activity against NDM-producing Klebsiella pneumoniae complex. Journal of global antimicrobial resistance, 2022, Volume: 28 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Ceftazidime; Cephalosporins; Klebsiella pneumoniae	2022
Genome characterization of a Klebsiella pneumoniae co-producing OXA-181 and KPC-121 resistant to ceftazidime/avibactam, meropenem/vaborbactam, imipenem/relebactam and cefiderocol isolated from a critically ill patient. Journal of global antimicrobial resistance, 2022, Volume: 30 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Boronic Acids; Cefiderocol; Ceftazidime; Cephalosporins; Critical Illness; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests	2022
Antimicrobial activity of cefepime/zidebactam (WCK 5222), a β-lactam/β-lactam enhancer combination, against clinical isolates of Gram-negative bacteria collected worldwide (2018-19). The Journal of antimicrobial chemotherapy, 2022, 09-30, Volume: 77, Issue:10 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Cefepime; Ceftazidime; Cephalosporins; Cyclooctanes; Enterobacteriaceae; Gram-Negative Bacteria; Hydrazines; Lactams; Microbial Sensitivity Tests; Piperidines; Pseudomonas aeruginosa; Tazobactam	2022
Activity of cefiderocol, imipenem/relebactam, cefepime/taniborbactam and cefepime/zidebactam against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy, 2022, 09-30, Volume: 77, Issue:10 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Borinic Acids; Carboxylic Acids; Cefepime; Cefiderocol; Ceftazidime; Cephalosporins; Cyclooctanes; Humans; Imipenem; Piperidines; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2022
Ceftolozane/Tazobactam and Ceftazidime/Avibactam: An Italian Multi-center Retrospective Analysis of Safety and Efficacy in Children With Hematologic Malignancies and Multi-drug Resistant Gram-negative Bacteria Infections. The Pediatric infectious disease journal, 2022, 12-01, Volume: 41, Issue:12 Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Child; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Hematologic Neoplasms; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Tazobactam	2022
Structural Basis of PER-1-Mediated Cefiderocol Resistance and Synergistic Inhibition of PER-1 by Cefiderocol in Combination with Avibactam or Durlobactam in Acinetobacter baumannii. Antimicrobial agents and chemotherapy, 2022, 12-20, Volume: 66, Issue:12 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Cefiderocol; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Microbial Sensitivity Tests	2022
Phenotypic and genotypic profile of ceftolozane/tazobactam-non-susceptible, carbapenem-resistant Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy, 2022, 12-23, Volume: 78, Issue:1 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Carbapenems; Cefepime; Ceftazidime; Cephalosporins; Drug Combinations; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2022
[Cefiderocol in AML patient with neutropenic infection due to 4MRGN Klebsiella pneumoniae (VIM-1)]. Deutsche medizinische Wochenschrift (1946), 2023, Volume: 148, Issue:4 Topics: Aged; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Cefiderocol; Ceftazidime; Cephalosporins; Colistin; Communicable Diseases; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Neoplasm Recurrence, Local; Neutropenia	2023
Simultaneous and divergent evolution of resistance to cephalosporin/β-lactamase inhibitor combinations and imipenem/relebactam following ceftazidime/avibactam treatment of MDR Pseudomonas aeruginosa infections. The Journal of antimicrobial chemotherapy, 2023, 05-03, Volume: 78, Issue:5 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Ceftazidime; Cephalosporinase; Cephalosporins; Drug Combinations; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2023
In vitro activity of cefepime/zidebactam and cefepime/taniborbactam against aztreonam/avibactam-resistant NDM-like-producing Escherichia coli clinical isolates. The Journal of antimicrobial chemotherapy, 2023, 05-03, Volume: 78, Issue:5 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; Cefepime; Cephalosporins; Escherichia coli; Microbial Sensitivity Tests	2023
Cefiderocol Resistance in Klebsiella pneumoniae Is Linked to SHV Extended-Spectrum β-Lactamase Activities and Functional Loss of the Outer Membrane Porin OmpK35. Microbiology spectrum, 2023, 06-15, Volume: 11, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactamases; Cefiderocol; Cephalosporins; Escherichia coli; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Porins	2023
Poor in vitro activity of ceftazidime/avibactam, ceftolozane/tazobactam, and meropenem/vaborbactam against carbapenem-resistant Pseudomonas aeruginosa in India: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2018-2021. The Journal of infection, 2023, Volume: 87, Issue:1 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Drug Combinations; Humans; Leadership; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2023
Resistance to aztreonam-avibactam due to a mutation of SHV-12 in Enterobacter. Annals of clinical microbiology and antimicrobials, 2023, Jun-26, Volume: 22, Issue:1 Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Ceftazidime; Cephalosporins; Drug Combinations; Enterobacter; Humans; Microbial Sensitivity Tests; Mutation	2023
High efficacy and enhanced synergistic activity of the novel siderophore-cephalosporin cefiderocol against multidrug-resistant and extensively drug-resistant Klebsiella pneumoniae from inpatients attending a single hospital in the United Arab Emirates. Journal of infection and public health, 2023, Volume: 16 Suppl 1 Topics: Anti-Bacterial Agents; beta-Lactamases; Cefiderocol; Cephalosporins; Hospitals; Humans; Inpatients; Iron; Kinetics; Klebsiella pneumoniae; Microbial Sensitivity Tests; Monobactams; Siderophores; United Arab Emirates	2023